BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 11498714)

  • 1. Effects of contextual or olfactory cues previously paired with morphine withdrawal on behavior and pain sensitivity in the rat.
    McNally GP; Akil H
    Psychopharmacology (Berl); 2001 Aug; 156(4):381-7. PubMed ID: 11498714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The anti-craving drug acamprosate inhibits the conditioned place aversion induced by naloxone-precipitated morphine withdrawal in rats.
    Kratzer U; Schmidt WJ
    Neurosci Lett; 1998 Aug; 252(1):53-6. PubMed ID: 9756357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditioned opioid withdrawal decreases nociceptin/orphanin FQ levels in the frontal cortex and olfactory tubercle.
    Walker JR; Terenius L; Koob GF
    Neuropsychopharmacology; 2002 Aug; 27(2):203-11. PubMed ID: 12093594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conditioned fear exacerbates acute morphine dependence.
    Abrahamsen GC; Caldarone BJ; Stock HS; Schutz AD; Rosellini RA
    Pharmacol Biochem Behav; 1995; 51(2-3):407-13. PubMed ID: 7667361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxytocin mediates the inhibitory action of acute lithium on the morphine dependence in rats.
    You ZD; Li JH; Song CY; Lu CL; He C
    Neurosci Res; 2001 Oct; 41(2):143-50. PubMed ID: 11591442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ibogaine interferes with motivational and somatic effects of naloxone-precipitated withdrawal from acutely administered morphine.
    Parke LA; Burton P; McDonald RV; Kim JA; Siegel S
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):293-7. PubMed ID: 11817506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discrete cues paired with naloxone-precipitated withdrawal from acute morphine dependence elicit conditioned withdrawal responses.
    Amitai N; Liu J; Schulteis G
    Behav Pharmacol; 2006 May; 17(3):213-22. PubMed ID: 16571999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anxiogenic-like effects of opiate withdrawal seen in the fear-potentiated startle test, an interdisciplinary probe for drug-related motivational states.
    Fendt M; Mucha RF
    Psychopharmacology (Berl); 2001 May; 155(3):242-50. PubMed ID: 11432686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enkephalin release promotes homeostatic increases in constitutively active mu opioid receptors during morphine withdrawal.
    Shoblock JR; Maidment NT
    Neuroscience; 2007 Nov; 149(3):642-9. PubMed ID: 17905519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditioned withdrawal in environments associated with the presence or absence of morphine.
    Schnur P; Wainwright M
    Pharmacol Biochem Behav; 1992 Mar; 41(3):543-6. PubMed ID: 1584832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentiated startle and hyperalgesia during withdrawal from acute morphine: effects of multiple opiate exposures.
    Harris AC; Hanes SL; Gewirtz JC
    Psychopharmacology (Berl); 2004 Nov; 176(3-4):266-73. PubMed ID: 15164157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative evaluation of opioid withdrawal signs in rats repeatedly treated with morphine and injected with naloxone, in the absence or presence of the antiabstinence agent clonidine.
    Pinelli A; Trivulzio S
    J Pharmacol Toxicol Methods; 1997 Nov; 38(3):117-31. PubMed ID: 9523765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of high-dose selegiline on morphine reinforcement and precipitated withdrawal in dependent rats.
    Grasing K; He S
    Behav Pharmacol; 2005 Feb; 16(1):1-13. PubMed ID: 15706133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of delta-opioid receptors in mediating the aversive stimulus effects of morphine withdrawal in the rat.
    Funada M; Schutz CG; Shippenberg TS
    Eur J Pharmacol; 1996 Apr; 300(1-2):17-24. PubMed ID: 8741160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of acute morphine withdrawal on ultrasonic vocalizations in adult rats: unchanged 50-kHz call rate and altered subtype profile.
    Lin YC; Zhao LL; Clarke PBS
    Psychopharmacology (Berl); 2018 Jul; 235(7):1945-1953. PubMed ID: 29663018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
    Stinus L; Cador M; Zorrilla EP; Koob GF
    Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinases in the rat nucleus accumbens are involved in the aversive component of opiate withdrawal.
    Valverde O; Tzavara E; Hanoune J; Roques BP; Maldonado R
    Eur J Neurosci; 1996 Dec; 8(12):2671-8. PubMed ID: 8996817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of alpha-lipoic acid administration on plasma glucose levels, total malondialdehyde values and withdrawal signs in rats treated with morphine or morphine plus naloxone.
    Pinelli A; Cighetti G; Trivulzio S
    Arzneimittelforschung; 2009; 59(2):72-8. PubMed ID: 19338137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of formalin-induced pain in morphine tolerance, withdrawal, and reward.
    Bardin L; Kim JA; Siegel S
    Exp Clin Psychopharmacol; 2000 Feb; 8(1):61-7. PubMed ID: 10743905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protracted manifestations of acute dependence after a single morphine exposure.
    Rothwell PE; Thomas MJ; Gewirtz JC
    Psychopharmacology (Berl); 2012 Feb; 219(4):991-8. PubMed ID: 21833504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.